An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
You’re asking what to do next after being on 15 mg of Mounjaro (tirzepatide) for months and hitting a plateau. In plain terms: the person lost a lot of weight on the drug but now isn’t losing the last 30–35 pounds they want, despite not overeating or craving carbs. They’re wondering if higher doses or other steps could help. Mounjaro is the brand name for tirzepatide. It’s a prescription injection that mimics two naturally occurring hormones from your gut that help control appetite and blood sugar. Think of it as a chemical message that tells your brain and body “you’re less hungry” and helps slow how fast food leaves your stomach. It’s used for type 2 diabetes and has been repurposed by many doctors to help with weight loss. Different doses exist; higher doses generally produce bigger effects but also raise the chance of side effects. What this personal report shows is a common pattern: strong initial weight loss, then a slowing or plateau. This snippet is an anecdote — one person’s experience — not a controlled study. Clinical trials of tirzepatide showed good weight-loss averages and that higher doses can produce more weight loss for many people, but responses vary. Plateaus are normal with any weight-loss method. Sometimes the body adapts, and weight loss tapers off. The snippet doesn’t tell us about other important details: activity level, exact diet, medical conditions, or whether a doctor discussed dose changes or other strategies. Why this matters: many people using drugs like Mounjaro hit plateaus and want a roadmap. Options a clinician might consider include checking for medical causes (thyroid problems, medications that cause weight gain), reviewing diet and exercise patterns, investigating whether muscle mass or water changes explain the stall, or discussing a dose change if clinically appropriate and approved in your country. For some patients, increasing the dose under medical supervision leads to further weight loss; for others, combining medication with structured lifestyle programs or different therapies helps. Knowing this gives people realistic expectations and prompts them to talk with their doctor. Important caveats: prescription decisions should be made with a clinician. Higher doses can increase side effects like nausea, diarrhea, vomiting, abdominal pain, and rarely more serious problems. Long-term safety beyond the lengths of current studies is still being studied. Some people can’t take these drugs because of a history of certain thyroid tumors or pancreatitis, so medical history matters. Also, a single person’s report can’t predict what will happen for someone else. If you’re considering a dose change, talk to your prescribing doctor about benefits, risks, monitoring labs, and other strategies for breaking a plateau. Bottom line: plateaus are common; speak with your clinician to check for medical issues and discuss whether a dose change, additional treatments, or lifestyle adjustments are the right next step.
Source: r/Mounjaro